Hashimoto's thyroiditis is associated with peripheral lymphocyte activation in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 23, Issue 1, 2005, Pages 43-49

  Farzati, Bartolomeo ^a   Mazziotti, Gherardo ^a   Cuomo, Giovanna ^a   Ressa, Marianna ^a   Sorvillo, Francesco ^a   Amato, Giovanni ^a   La Montagna, Giovanni ^a   Carella, Carlo ^a   Valentini, Gabriele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Hashimoto's thyroiditis; Systemic sclerosis; T lymphocytes; Th1 Th2 cytokines

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; LEVOTHYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUPPRESSOR CELL; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AUTOIMMUNITY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; THYROIDITIS, AUTOIMMUNE;

EID: 15844393092     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. SALGAME P, ABRAMS JS, CLAYBERGER C et al.: Differing lymphokine profiles of functional subset of human CD4 and CD8 T cell clones. Science 1991; 254: 279-82.
2. CARTER LL, DUTTON RW: Type 1 and Type 2: a fundamental dichotomy for a T-cell sub-sets. Curr Opin Immunol 1996; 24: 336-42.
3. MOSMANN TR, SAD S: 1996 The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
4. ROMAGNANI S: T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000; 85: 9-18.
5. LUCEY DR, CLERICI M, SHEARER GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996; 9: 532-62.
6. LeROY EC: Systemic sclerosis (sclerodermia). In BENNET JC, PLUMM F and GLASS DN (Eds): Cecil Textbook of Medicine. Philadelphia, W.B. Saunders 1996: 1483.
7. KAHALEH B: Immunologic aspects of sclerodermia. Curr Opin Rheumatol 1993; 5: 760-5.
8. FIOCCO U, ROSADA M, COZZI L et al.: Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity. Ann Rheum Dis 1993; 52: 272-7.
9. GIACOMELLI R, CIPRIANI P, LATTANZIO R et al.: Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. Clin Exp Immunol 1997; 108: 42-6.
10. MAVILIA C, SCALETTI C, ROMAGNANI P et al.: Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997; 151: 1751-8.
11. HASEGAWA M, FUJIMOTO M, KIKUCHI K, TAKEHARA K: Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. J Rheumatol 1997; 24: 663-5.
12. SATO S, HANAKAWA H, HASEGAWA M et al.: Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis. J Rheumatol 2000; 27: 2838-42.
13. FUJII H, HASEGAWA M, TAKEHARA K, MUKAIDA N, SATO S: Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis. Clin Exp Immunol 2002; 130: 548-56.
14. VALENTINI G, ROMANO MF, NACLERIO C et al.: Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmunity 2000; 15: 61-8.
15. VALENTINI G, BARONI A, ESPOSITO K et al.: Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol 2001; 21: 210-7.
16. KAHL L.E., MEDSGER , T.A. Jr, KLEIN I: Prospective evaluation of thyroid function in patients with systemic sclerosis (Scleroderma). J Rheumatol 1986; 13: 103-7.
17. LA MONTAGNA G, CARELLA C, AMATO G, FILIPPI F, BELLASTELLA A, TIRRI G: Thyroid function in patients with Systemic Sclerosis. Connec Tissue Dis 1989; 8: 13-21.
18. MASI AT, RODNAN GP, MEDSGER TA et al.: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
19. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-5.
20. PEARCE EN, FARWELL AP, BRAVERMAN LE: Thyroiditis. N Eng J Med 2003; 348: 2646-55.
21. MAZZIOTTI G, SORVILLO F, IORIO S et al.: Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto's thyroiditis. Clin Endocrinol2003; 59: 223-9.
22. DINTER A, BERGER EG: Golgi-disturbing agents. Histochem Cell Biol 1998; 109: 571-90.
23. PALA P, HUSSEL T, OPENSHAW JM: Flow cytometric measurement of intracellular cytokines. J Immunol Methods 2000; 243: 107-24.
24. KOVACS EJ: Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-23.
25. LUDGATE ME, MAZZIOTTI G: Autoimmune thyroid disease. In DEKKER M et al. (Eds.): Immunoendocrinology in Health and Disease. New York, Geenen/Chrousos, 2004 (in press).
26. VIGNALI DA: Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-55.
27. UEDA M, ICHIYAMA S, SUGAWA H: Thyroid specific T helper cell analysis by ELISPOT assay with thyrotropin receptor (TSH-R) peptides. Peptides 2002; 23: 103-7.
28. PRUSSIN C: Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J Clin Immunol 1997; 17: 195-204.
29. WEISS A: T lymphocyte activation. In PAUL W (Eds.): Fundamental Immunology. New York: Lippincott Williams & Wilkins, 1998: 411.
30. CARAHER EM, PARENTEAU M, GRUBER H, SCOTT FW: Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen. J Immunol Methods 2000; 244: 29-40.
31. MANGER B, WEISS A, IMBODEN J, LAING T, STOBO JD: The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies. J Immunol 1987; 139: 2755-60.
32. ROURA-MIR C, CATALFAMO M, SOSPEDRA M, ALCALDE L, PUJOL-BORRELL, JARAQUEMADA D: Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Eur J Immunol 1997; 27: 3290-302.
33. De LA VEGA JR, VILAPLANA JC, BIRO A, HAMMOND L, BOTTAZZO GF, MIRAKIAN R: IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? J Exp Immunol 1998; 113: 126-35.
34. MAZZIOTTI G, SORVILL0 F, NACLERIO C et al.: Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis. Eur J Endocrinol 2003; 148: 383-8.
35. MARAZUELA M: Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol 1999; 140: 287-90.
36. GESSL A, WILFING A, AGIS H et al.: Activated naive CD4+ peripheral blood T cells in autoimmune thyroid disease. Thyroid 1995; 5: 117-25.
37. CIAMPOLILLO A, GUASTAMACCHIA E, AMATI L et al.: Modifications of the immune responsiveness in patients with autoimmune thyroiditis: evidence for a systemic immune alteration. Curr Pharm Des 2003; 9: 1946-50.
38. MAZZIOTTI G, AMATO G, CARELLA C: Is chronic autoimmune thyroiditis a systemic disease? Am J Med 2003; 115: 412-3.
39. MATALON ST, BLANK M, ORNOY A, SHOENFELD Y: The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 2001; 45: 72-7.
40. HARRIS B, ORETTI R, LAZARUS J et al.: Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psych 2002; 180: 327-30.
41. KAHL LE, MEDSGER TA Jr, KLEIN I: Prospective evaluation thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986, 13: 103-7.
42. LA MONTAGNA G, CARELLA C, AMATO G, FILIPPI F, BELLASTELLA A, TIRRI G: Thyroid function in systemic sclerosis. J Endocrinol Invest 1992; 15: 309-10.